Trial Profile
Second phase I/II study of MT-102 in patients with Cachexia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Jan 2023
Price :
$35
*
At a glance
- Drugs Espindolol (Primary)
- Indications Cachexia
- Focus Adverse reactions
- Sponsors Akamis Bio; PsiOxus Therapeutics
- 05 Jan 2023 According to an Akamis Bio media release, PsiOxus Therapeutics has changed its name to Akamis Bio.
- 23 Feb 2016 New trial record